Genetic and environment play a significant role in the etiology of essential hypertension (EH). Recently STK39 rs3754777, ATP2B1 rs2681472 and rs17249754 have been associated with BP variation and hypertension. In this study we aimed to determine firstly whether index variants were associated with the risk of developing EH in Burkina Faso and secondly to characterize cardiovascular risk markers. We conducted a case-control study with 380 participants including 180 case subjects with EH and 200 control subjects with normal BP. We used TaqMan genotyping assays with probes from Applied Biosystems to genotype polymorphisms using the 7500 Real-Time PCR System. Biochemical parameters were measured using chemistry analyzer COBAS C311. T-test showed that cardiovascular risk markers such as body mass index, waist circumference, blood sugar, total cholesterol and triglycerides were significantly higher in hypertensive compared to normotensive (all p < 0.05). Binary logistic regression analysis revealed in decreasing order that overweight, family history of hypertension, central obesity and alcohol intake increased the risk of developing EH (all OR > 3.8; all p < 0.001). In genetic level we observed that individuals carrying the AA+AG genotype of ATP2B1 rs17249754 had a low risk of developing EH than those carrying the GG genotype (OR = 0.48 [95% CI: 0.31–0.75] p = 0.001) and the A allele frequency in the cases was significantly lower than that of the controls (OR = 0.56 [95% CI: 0.38–0.82] p = 0.003). We also observed that ATP2B1 rs17249754 was significantly associated with higher SBP and DPB in case and control groups (GG versus AG + AA; p < 0.05), ATP2B1 rs2681472 was significantly associated with higher SBP only in case and control group (AA versus AG + GG; p < 0.05), STK39 rs3754777 was not significantly associated with any of the BP traits (CC versus CT + TT; p > 0.05). Our results confirmed the significant association of ATP2B1 rs17249754 with the risk of developing EH in Burkinabe and showed an increase of cardiovascular risk markers levels in subjects with EH.
Cancer is a controllable disease with advanced medical approaches and stakeholder collaborative efforts. Despite significant financial investments in cancer research, progress remains limited, particularly in sub-Saharan Africa (SSA), where most cancer types remain understudied. This review provides a comprehensive analysis of current trends in cancer education, awareness, and screening uptake in SSA. It also identifies prospects for advancing cancer education and sustaining research efforts in the region. We included 86 studies in this review, synthesizing evidence from systematic reviews and meta-analyses to present an unbiased overview of SSA-specific trends. A structured table was derived from 52 studies, comprising 26 on cervical cancer, 10 on breast cancer, and 16 on other cancer types. The review highlights positive outcomes from awareness campaigns of the included designs. However, low participant retention in trials and underdeveloped research infrastructure in SSA have hindered the translation of awareness into clinical trial participation and vaccine uptake. While the review identifies promising preventive, predictive, and personalized approaches for cancer awareness in SSA, it calls for more rigorous study designs with robust data analysis to address potential biases. Furthermore, sustained financial and cultural support is critical to align future research with SSA’s healthcare priorities and societal perceptions.